Towards improved respiratory outcomes in preterm infants through rapid and effective aerosalisation of medication to the lung [ 2017 - ]

Research Grant

Researchers: Dr Anushi Rajapaksa (Principal investigator)

Brief description Babies born premature are greatest at risk from increasingly common respiratory illnesses. It is possible that delivering a medication by aerosol will be the most effective method of treatment. For premature babies that need breathing support, inhaled medication could improve care. For highly infectious respiratory illnesses such as RSV, with no vaccines available, we need to protect babies very early in life. I will use an established lamb model to test fast medication delivery to the lungs.

Funding Amount $318,768.00

Funding Scheme Early Career Fellowships

Notes Peter Doherty Biomedical ECF